{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Durham",
      "address_1": "100 Rodolphe St",
      "reason_for_recall": "False resistant results for Streptococcus anginosus and Streptococcus constellatus strains were reported.",
      "address_2": "",
      "product_quantity": "184,374",
      "code_info": "Catalog # 410028, VITEK 2 AST-ST01  Catalog # 420915, VITEK 2 AST-ST02  Catalog # 421040, VITEK 2 AST-ST03",
      "center_classification_date": "20181217",
      "distribution_pattern": "Worldwide Distribution: US (nationwide) to states of: AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, NV, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, WV, WY including Puerto Rico and to countries of:Algeria, Angola,  Azerbaijan, Bahrain, Bangladesh, Belarus, Sarl, Benin, Bosnia-Herz, Cameroon, Chad, Cote d'Ivoire, Croatia, Dem. Rep. Congo, Egypt, , Georgia, Guam, Ethiopia, Iraq, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, UAB, Lithuania, Macedonia, Malta, Mongolia, Morocco, Mozambique, Niger, Oman, Pakistan, Palestine, Qatar, Romania,  Saudi Arabia, Senegal, Serbia, Slovenia, Sri Lanka, Tunisia, Ukraine, Gabon, and Zimbabwe.",
      "state": "NC",
      "product_description": "VITEK 2 Antimicrobial Susceptibility Testing (AST) using one or more of these susceptibility products:  Catalog # 410028, VITEK 2 AST-ST01  Catalog # 420915, VITEK 2 AST-ST02  Catalog # 421040, VITEK 2 AST-ST03       The VITEK 2 Streptococcus Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of S. pneumoniae, beta-hemolytic Streptococcus, and Viridans Streptococcus to antimicrobial agents when used as instructed.",
      "report_date": "20181226",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "bioMerieux, Inc.",
      "recall_number": "Z-0618-2019",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "81415",
      "termination_date": "20191104",
      "more_code_info": "",
      "recall_initiation_date": "20181022",
      "postal_code": "27712-9402",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}